{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:42:34Z","timestamp":1793972554061,"version":"4.8.0"},"reference-count":53,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>On July 7, 1999, the American Academy of Pediatrics and the US Public Health Service issued a joint statement calling for removal of thimerosal, a mercury-containing preservative, from vaccines. This action was prompted in part by a risk assessment from the Food and Drug Administration that is presented here.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>The risk assessment consisted of hazard identification, dose-response assessment, exposure assessment, and risk characterization. The literature was reviewed to identify known toxicity of thimerosal, ethylmercury (a metabolite of thimerosal) and methylmercury (a similar organic mercury compound) and to determine the doses at which toxicity occurs. Maximal potential exposure to mercury from vaccines was calculated for children at 6 months old and 2 years, under the US childhood immunization schedule, and compared with the limits for mercury exposure developed by the Environmental Protection Agency (EPA), the Agency for Toxic Substance and Disease Registry, the Food and Drug Administration, and the World Health Organization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Delayed-type hypersensitivity reactions from thimerosal exposure are well-recognized. Identified acute toxicity from inadvertent high-dose exposure to thimerosal includes neurotoxicity and nephrotoxicity. Limited data on toxicity from low-dose exposures to ethylmercury are available, but toxicity may be similar to that of methylmercury. Chronic, low-dose methylmercury exposure may cause subtle neurologic abnormalities. Depending on the immunization schedule, vaccine formulation, and infant weight, cumulative exposure of infants to mercury from thimerosal during the first 6 months of life may exceed EPA guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Our review revealed no evidence of harm caused by doses of thimerosal in vaccines, except for local hypersensitivity reactions. However, some infants may be exposed to cumulative levels of mercury during the first 6 months of life that exceed EPA recommendations. Exposure of infants to mercury in vaccines can be reduced or eliminated by using products formulated without thimerosal as a preservative.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.107.5.1147","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"1147-1154","source":"Crossref","is-referenced-by-count":253,"title":["An Assessment of Thimerosal Use in Childhood Vaccines"],"prefix":"10.1542","volume":"107","author":[{"given":"Leslie K.","family":"Ball","sequence":"first","affiliation":[{"name":"From the Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[{"name":"From the Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Douglas","family":"Pratt","sequence":"additional","affiliation":[{"name":"From the Division of Vaccines and Related Products Applications, Office of Vaccines Research and Review, and the"},{"name":"Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"2021121009450519500_B1"},{"key":"2021121009450519500_B2","first-page":"563","article-title":"Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.","volume":"48","author":"Notice to Readers","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121009450519500_B3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.104.3.570","article-title":"Thimerosal in vaccines\u2014an interim report to clinicians.","volume":"104","author":"American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Environmental Health","year":"1999","journal-title":"Pediatrics"},{"key":"2021121009450519500_B4"},{"key":"2021121009450519500_B5"},{"key":"2021121009450519500_B6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0092-1157(78)80022-5","article-title":"Assay for mercurial preservatives in biological products by cold-vapor atomic absorption spectrophotometry.","volume":"6","author":"May","year":"1978","journal-title":"J Biol Stand"},{"key":"2021121009450519500_B7"},{"key":"2021121009450519500_B8","first-page":"826","article-title":"Abscesses complicating DTP vaccination.","volume":"135","author":"Bernier","year":"1981","journal-title":"Am J Dis Child"},{"key":"2021121009450519500_B9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006454-199305000-00003","article-title":"Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccine.","volume":"12","author":"Simon","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009450519500_B10"},{"key":"2021121009450519500_B11"},{"key":"2021121009450519500_B12"},{"key":"2021121009450519500_B13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/phr\/114.5.397","article-title":"Methylmercury: a new look at the risks.","volume":"114","author":"Mahaffey","year":"1999","journal-title":"Public Health Rep"},{"key":"2021121009450519500_B14"},{"key":"2021121009450519500_B15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS).","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"2021121009450519500_B16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0300-483X(75)90082-7","article-title":"Tissue concentrations of mercury after chronic dosing of squirrel monkeys with thimerosal.","volume":"3","author":"Blair","year":"1975","journal-title":"Toxicology"},{"key":"2021121009450519500_B17","first-page":"296","article-title":"Merthiolate as a germicide.","volume":"13","author":"Powell","year":"1931","journal-title":"Am J Hyg"},{"key":"2021121009450519500_B18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15563657108990959","article-title":"Toxicology and carcinogenesis of various chemicals used in the preparation of vaccines.","volume":"4","author":"Mason","year":"1971","journal-title":"Clin Toxicol"},{"key":"2021121009450519500_B19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0536.1988.tb02809.x","article-title":"Thimerosal allergy and vaccination reactions.","volume":"18","author":"Cox","year":"1988","journal-title":"Contact Dermatitis"},{"key":"2021121009450519500_B20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0536.1996.tb02174.x","article-title":"Hypersensitivity to thimerosal: the sensitivity moiety.","volume":"34","author":"Goncalo","year":"1996","journal-title":"Contact Dermatitis"},{"key":"2021121009450519500_B21","first-page":"1387","article-title":"Immunologic necessities: diluents, adjuvants, and excipients.","volume":"31","author":"Grabenstein","year":"1996","journal-title":"Hosp Pharm"},{"key":"2021121009450519500_B22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0536.1994.tb01989.x","article-title":"All these positive tests to thimerosal.","volume":"31","author":"Moller","year":"1994","journal-title":"Contact Dermatitis"},{"key":"2021121009450519500_B23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0140-6736(91)90455-X","article-title":"The case against thiomersal.","volume":"338","author":"Seal","year":"1991","journal-title":"Lancet"},{"key":"2021121009450519500_B24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0536.1995.tb00764.x","article-title":"Sensitization to thimerosal and previous vaccination.","volume":"32","author":"Schafer","year":"1995","journal-title":"Contact Dermatitis"},{"key":"2021121009450519500_B25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3476(80)80159-4","article-title":"Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin.","volume":"97","author":"Matheson","year":"1980","journal-title":"J Pediatr"},{"key":"2021121009450519500_B26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(96)90061-6","article-title":"Mercury poisoning associated with hepatitis B immunoglobulin.","volume":"347","author":"Lowell","year":"1996","journal-title":"Lancet"},{"key":"2021121009450519500_B27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/pgmj.48.561.417","article-title":"Six cases of poisoning after a parenteral organic mercurial compound (merthiolate).","volume":"48","author":"Axton","year":"1972","journal-title":"Postgrad Med J"},{"key":"2021121009450519500_B28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(84)81021-5","article-title":"Mercury toxicity following merthiolate ear irrigations.","volume":"104","author":"Rohyans","year":"1994","journal-title":"J Pediatr"},{"key":"2021121009450519500_B29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/adc.52.12.962","article-title":"Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic.","volume":"52","author":"Fagan","year":"1977","journal-title":"Arch Dis Child"},{"key":"2021121009450519500_B30","first-page":"453","article-title":"Clinical course of severe poisoning with thiomersal.","volume":"34","author":"Pfab","year":"1996","journal-title":"Clin Toxicol"},{"key":"2021121009450519500_B31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00324789","article-title":"The comparative toxicology of ethyl- and methylmercury.","volume":"57","author":"Magos","year":"1985","journal-title":"Arch Toxicol"},{"key":"2021121009450519500_B32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajim.4700050308","article-title":"Clinical observations in ethyl mercury chloride poisoning.","volume":"5","author":"Zhang","year":"1984","journal-title":"Am J Ind Med"},{"key":"2021121009450519500_B33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pa.12.040172.002111","article-title":"The pharmacology of mercury compounds.","volume":"12","author":"Clarkson","year":"1972","journal-title":"Annu Rev. Pharmacol"},{"key":"2021121009450519500_B34"},{"key":"2021121009450519500_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408449509089885","article-title":"Minamata disease: Methylmercury poisoning in Japan caused by environmental pollution.","volume":"25","author":"Harada","year":"1995","journal-title":"Crit Rev Toxicol"},{"key":"2021121009450519500_B36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.181.4096.230","article-title":"Methylmercury poisoning in Iraq.","volume":"181","author":"Bakir","year":"1973","journal-title":"Science"},{"key":"2021121009450519500_B37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.280.8.701","article-title":"Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles child development study.","volume":"280","author":"Davidson","year":"1998","journal-title":"JAMA"},{"key":"2021121009450519500_B38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0892-0362(97)00097-4","article-title":"Cognitive deficit in 7 year old children with prenatal exposure to methylmercury.","volume":"6","author":"Grandjean","year":"1997","journal-title":"Neurotoxicol Teratol"},{"key":"2021121009450519500_B39"},{"key":"2021121009450519500_B40"},{"key":"2021121009450519500_B41"},{"key":"2021121009450519500_B42"},{"key":"2021121009450519500_B43"},{"key":"2021121009450519500_B44","first-page":"780","article-title":"Availability of hepatitis B vaccine that does not contain thimerosal as a preservative.","volume":"48","author":"Notice to Readers","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121009450519500_B45"},{"key":"2021121009450519500_B46"},{"key":"2021121009450519500_B47"},{"key":"2021121009450519500_B48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mpd.2000.105133","article-title":"Iatrogenic exposure to mercury following hepatitis B vaccination in preterm infants.","volume":"136","author":"Stajich","year":"2000","journal-title":"J Pediatr"},{"key":"2021121009450519500_B49"},{"key":"2021121009450519500_B50","first-page":"12","article-title":"Thimerosal as a vaccine preservative.","volume":"75","author":"World Health Organization","year":"2000","journal-title":"Wkly Epidemiol Rec"},{"key":"2021121009450519500_B51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)74714-0","article-title":"Thiomersal as a vaccine preservative.","volume":"355","author":"Clements","year":"2000","journal-title":"Lancet"},{"key":"2021121009450519500_B52"},{"key":"2021121009450519500_B53","first-page":"996","article-title":"Recommendations regarding the use of vaccines that contain thimerosal as a preservative.","volume":"48","author":"Notice to Readers","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/5\/1147\/893023\/1147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/5\/1147\/893023\/1147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:44:37Z","timestamp":1639172677000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/5\/1147\/66202\/An-Assessment-of-Thimerosal-Use-in-Childhood"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,5,1]]},"published-print":{"date-parts":[[2001,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.5.1147","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5,1]]}}}